메뉴 건너뛰기




Volumn 27, Issue 12, 2005, Pages 1930-1941

Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: Analysis of a multicenter, rater-blinded, open-label study

Author keywords

Atypical antipsychotics; Metabolic syndrome; Olanzapine; Prevalence; Risperidone

Indexed keywords

OLANZAPINE; RISPERIDONE;

EID: 33644515983     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2005.12.005     Document Type: Article
Times cited : (56)

References (35)
  • 1
    • 2542509446 scopus 로고    scopus 로고
    • Mortality and causes of death in schizophrenia in Stockholm county, Sweden
    • Osby U., Correia N., and Brandt L. Mortality and causes of death in schizophrenia in Stockholm county, Sweden Schiz Res 45 2000 21 28
    • (2000) Schiz Res , vol.45 , pp. 21-28
    • Osby, U.1    Correia, N.2    Brandt, L.3
  • 2
    • 2342641227 scopus 로고    scopus 로고
    • Cardiovascular illness and hyperlipidemia in patients with schizophrenia
    • Meyer J.M. Nasrallah H. American Psychiatric Press, Inc Washington, DC
    • Meyer J.M. Cardiovascular illness and hyperlipidemia in patients with schizophrenia Meyer J.M. Nasrallah H. Medical Illness and Schizophrenia 2003 American Psychiatric Press, Inc Washington, DC 59 89
    • (2003) Medical Illness and Schizophrenia , pp. 59-89
    • Meyer, J.M.1
  • 4
    • 0034837376 scopus 로고    scopus 로고
    • Cardiovascular morbidity and mortality associated with the metabolic syndrome
    • Isomaa B., Almgren P., and Tuomi T. Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 24 2001 683 689
    • (2001) Diabetes Care , vol.24 , pp. 683-689
    • Isomaa, B.1    Almgren, P.2    Tuomi, T.3
  • 5
    • 0035897696 scopus 로고    scopus 로고
    • Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
    • Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
    • (2001) JAMA , vol.285 , pp. 2486-2497
  • 6
    • 0842277242 scopus 로고    scopus 로고
    • Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientificissues related to definition
    • Grundy S.M., Brewer B., and Cleeman J.I. American Heart Association and the National Heart, Lung, and Blood Institute Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientificissues related to definition Circulation 109 2004 433 438
    • (2004) Circulation , vol.109 , pp. 433-438
    • Grundy, S.M.1    Brewer, B.2    Heart Association, C.3    National Heart, T.4    Lung5    Blood Institute, J.I.6
  • 7
    • 0037116641 scopus 로고    scopus 로고
    • Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey
    • Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey JAMA 287 2002 356 359
    • (2002) JAMA , vol.287 , pp. 356-359
    • Ford, E.S.1    Giles, W.H.2    Dietz, W.H.3
  • 8
    • 4644279733 scopus 로고    scopus 로고
    • Increasing prevalence of the metabolic syndrome among US adults
    • Ford E.S., Giles W.H., and Mokdad A.H. Increasing prevalence of the metabolic syndrome among US adults Diabetes Care 27 2004 2444 2449
    • (2004) Diabetes Care , vol.27 , pp. 2444-2449
    • Ford, E.S.1    Giles, W.H.2    Mokdad, A.H.3
  • 9
    • 0037463608 scopus 로고    scopus 로고
    • The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994
    • Park Y.W., Zhu S., and Palaniappan L. The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994 Arch Intern Med 163 2003 427 436
    • (2003) Arch Intern Med , vol.163 , pp. 427-436
    • Park, Y.W.1    Zhu, S.2    Palaniappan, L.3
  • 10
    • 1842844950 scopus 로고    scopus 로고
    • Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
    • American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, and North American Association for the Study of Obesity Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes J Clin Psychiatry 65 2004 267 272
    • (2004) J Clin Psychiatry , vol.65 , pp. 267-272
  • 11
    • 0033756432 scopus 로고    scopus 로고
    • Prevalence and correlates of diabetes in national schizophrenia samples
    • Dixon L., Weiden P., and Delahanty J. Prevalence and correlates of diabetes in national schizophrenia samples Schizophren Bull 26 2000 903 912
    • (2000) Schizophren Bull , vol.26 , pp. 903-912
    • Dixon, L.1    Weiden, P.2    Delahanty, J.3
  • 12
    • 1842684117 scopus 로고    scopus 로고
    • Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia
    • Bushe C., and Holt R. Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia Br J Psychiatry Suppl 47 2004 S67 S71
    • (2004) Br J Psychiatry Suppl , vol.47
    • Bushe, C.1    Holt, R.2
  • 13
    • 27744502054 scopus 로고    scopus 로고
    • Prevalence of the metabolic syndrome in patients with schizophre nia: Baseline results from the Clinical Antipsychotic Trials of InterventionEffectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III
    • McEvoy J.P., Meyer J.M., and Goff D.C. Prevalence of the metabolic syndrome in patients with schizophre nia: Baseline results from the Clinical Antipsychotic Trials of InterventionEffectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III Schizophr Res 80 2005 19 32
    • (2005) Schizophr Res , vol.80 , pp. 19-32
    • McEvoy, J.P.1    Meyer, J.M.2    Goff, D.C.3
  • 14
    • 0038448311 scopus 로고    scopus 로고
    • The National Institute of Mental Health Clinical Antipsy chotic Trials of Intervention Effectiveness (CATIE) project: Schizophrenia trial design and protocol development
    • Stroup T.S., McEvoy J.P., and Swartz M.S. The National Institute of Mental Health Clinical Antipsy chotic Trials of Intervention Effectiveness (CATIE) project: Schizophrenia trial design and protocol development Schizophr Bull 29 2003 15 31
    • (2003) Schizophr Bull , vol.29 , pp. 15-31
    • Stroup, T.S.1    McEvoy, J.P.2    Swartz, M.S.3
  • 16
    • 4043123270 scopus 로고    scopus 로고
    • The prevalence of the metabolic syndrome in patients with schizo affective disorder-bipolar subtype
    • Basu R., Brar J.S., and Chengappa K.N. The prevalence of the metabolic syndrome in patients with schizo affective disorder-bipolar subtype Bipolar Disord 6 2004 314 318
    • (2004) Bipolar Disord , vol.6 , pp. 314-318
    • Basu, R.1    Brar, J.S.2    Chengappa, K.N.3
  • 17
    • 11844270509 scopus 로고    scopus 로고
    • Characterizing coronary heart disease risk in chronic schizophre nia: High prevalence of the metabolic syndrome
    • Cohn T., Prud'homme D., and Streiner D. Characterizing coronary heart disease risk in chronic schizophre nia: High prevalence of the metabolic syndrome Can J Psychiatry 49 2004 753 760
    • (2004) Can J Psychiatry , vol.49 , pp. 753-760
    • Cohn, T.1    Prud'Homme, D.2    Streiner, D.3
  • 21
    • 33644509605 scopus 로고    scopus 로고
    • Prevalence of the metabolicsyndrome in veterans with schizophrenia
    • In press.
    • Meyer JM, Loh C, Leckband SG. Prevalence of the metabolicsyndrome in veterans with schizophrenia. J Psych Pract. In press.
    • J Psych Pract
    • Meyer, J.M.1    Loh, C.2    Leckband, S.G.3
  • 22
    • 0035684803 scopus 로고    scopus 로고
    • Effects of atypical antipsychotics on weight and serum lipid levels
    • Meyer J.M. Effects of atypical antipsychotics on weight and serum lipid levels J Clin Psychiatry 62 Suppl 27 2001 27 34
    • (2001) J Clin Psychiatry , vol.62 , Issue.27 SUPPL. , pp. 27-34
    • Meyer, J.M.1
  • 23
    • 0036001466 scopus 로고    scopus 로고
    • Phenomenology of and risk factors for newonset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: An analysis of 45 published cases
    • Jin H., Meyer J.M., and Jeste D.V. Phenomenology of and risk factors for newonset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: An analysis of 45 published cases Ann Clin Psychiatry 14 2002 59 64
    • (2002) Ann Clin Psychiatry , vol.14 , pp. 59-64
    • Jin, H.1    Meyer, J.M.2    Jeste, D.V.3
  • 24
    • 3342901698 scopus 로고    scopus 로고
    • Physical health monitoring of patients with schizophrenia
    • Marder S.R., Essock S.M., and Miller A.L. Physical health monitoring of patients with schizophrenia Am J Psychiatry 161 2004 1334 1349
    • (2004) Am J Psychiatry , vol.161 , pp. 1334-1349
    • Marder, S.R.1    Essock, S.M.2    Miller, A.L.3
  • 25
    • 0345107248 scopus 로고    scopus 로고
    • Improvement in indices of health status in outpatients with schizophrenia switched to ziprasidone
    • Weiden P.J., Daniel D.G., Simpson G.M., and Romano S.J. Improvement in indices of health status in outpatients with schizophrenia switched to ziprasidone J Clin Psychopharmacol 23 2003 595 600
    • (2003) J Clin Psychopharmacol , vol.23 , pp. 595-600
    • Weiden, P.J.1    Daniel, D.G.2    Simpson, G.M.3    Romano, S.J.4
  • 27
    • 14644439810 scopus 로고    scopus 로고
    • Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder
    • Brar J.S., Ganguli R., and Pandina G. Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder J Clin Psychiatry 66 2005 205 212
    • (2005) J Clin Psychiatry , vol.66 , pp. 205-212
    • Brar, J.S.1    Ganguli, R.2    Pandina, G.3
  • 29
    • 0023606101 scopus 로고
    • The positive and negative syndrome scale (PANSS) for schizophrenia
    • Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia Schizophr Bull 13 1987 261 276
    • (1987) Schizophr Bull , vol.13 , pp. 261-276
    • Kay, S.R.1    Fiszbein, A.2    Opler, L.A.3
  • 30
    • 0037317444 scopus 로고    scopus 로고
    • Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia
    • Ryan M.C., Collins P., and Thakore J.H. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia Am J Psychiatry 160 2003 284 289
    • (2003) Am J Psychiatry , vol.160 , pp. 284-289
    • Ryan, M.C.1    Collins, P.2    Thakore, J.H.3
  • 31
    • 1142285313 scopus 로고    scopus 로고
    • The effects of atypical antipsychotics on visceral fat distribu tion in first episode, drug-naive patients with schizophrenia
    • [published correction appears in Life Sci. 2004; 75:2851] Ryan M.C., Flanagan S., and Kinsella U. The effects of atypical antipsychotics on visceral fat distribu tion in first episode, drug-naive patients with schizophrenia Life Sci 74 2004 1999 2008
    • (2004) Life Sci , vol.74 , pp. 1999-2008
    • Ryan, M.C.1    Flanagan, S.2    Kinsella, U.3
  • 32
    • 0346373688 scopus 로고    scopus 로고
    • Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia
    • Zhang Z.J., Yao Z.J., and Liu W. Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia Br J Psychiatry 184 2004 58 62
    • (2004) Br J Psychiatry , vol.184 , pp. 58-62
    • Zhang, Z.J.1    Yao, Z.J.2    Liu, W.3
  • 33
    • 1842666845 scopus 로고    scopus 로고
    • The metabolic syndrome and mortality from cardiovascular disease and all-causes: Findings from the National Health and Nutrition Examination Survey II Mortality Study
    • Ford E.S. The metabolic syndrome and mortality from cardiovascular disease and all-causes: Findings from the National Health and Nutrition Examination Survey II Mortality Study Atherosclerosis 173 2004 309 314
    • (2004) Atherosclerosis , vol.173 , pp. 309-314
    • Ford, E.S.1
  • 34
    • 85060840150 scopus 로고    scopus 로고
    • Acomprehensive review of behavioral interventions for weight management in schizophrenia
    • In press.
    • Loh C, Meyer JM, Leckband SG. Acomprehensive review of behavioral interventions for weight management in schizophrenia. Ann Clin Psychiatry. In press.
    • Ann Clin Psychiatry
    • Loh, C.1    Meyer, J.M.2    Leckband, S.G.3
  • 35
    • 4544276308 scopus 로고    scopus 로고
    • Guidelines for prevention and treatment of adverse effects of anti psychotic drugs on glucose-insulin homeostasis and lipid metabolism
    • Melkersson K.I., Dahl M.L., and Hulting A.L. Guidelines for prevention and treatment of adverse effects of anti psychotic drugs on glucose-insulin homeostasis and lipid metabolism Psychopharmacology (Berl) 175 2004 1 6
    • (2004) Psychopharmacology (Berl) , vol.175 , pp. 1-6
    • Melkersson, K.I.1    Dahl, M.L.2    Hulting, A.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.